Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug [Phase 2]
Phase 2 study using [F-18]RGD-K5 PET to monitor response to an anti-angiogenic cancer therapy has completed, with enrollment spanning metast…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection [NA]
This clinical trial update notes completion and posted results for a study evaluating fast-track rehabilitation after elective colorectal an…
-
FDA approval · 2012-08-17FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for VECTIBIX (panitumumab) by Amgen, approving an updated labeling and indication for the product.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus [Phase 2]
The document reports updated results from a Phase 2 expanded cohort studying bevacizumab plus everolimus in metastatic colorectal cancer.
-
CLINICAL_TRIALS research · 2012-08-14Clinical Trial Update: Application of CO2 Insufflations in Colonoscopy Randomized Trial [NA]
Clinical trial update evaluating CO2 insufflation during colonoscopy for colorectal neoplasms and colorectal cancer; status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
A completed Stanford-led clinical trial evaluated the feasibility of using Avastin (bevacizumab) with [18-F]-labeled 5-fluorouracil PET/CT i…
-
CLINICAL_TRIALS withdrawal · 2012-08-10Clinical Trial Update: Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project
The PET-CT Cetuximab Project trial for metastatic colorectal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Rehabilitation Following Laparoscopic Colonic Surgery [NA]
Completed clinical trial evaluating rehabilitation following laparoscopic colon cancer surgery.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer [Phase 3]
This Phase 3 trial assesses adjuvant chemotherapy using fluorouracil and leucovorin with or without irinotecan after surgery for Stage III c…
-
FDA approval · 2012-08-07FDA Approved: OXALIPLATIN — Original Application (Mylan Institutional LLC)
FDA approved the Original Application for a generic oxaliplatin product manufactured by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery [Phase 2]
Phase 2 trial evaluating the efficacy of a single-incision embryonic NOTES laparoscopic approach for colorectal cancer has completed. Sponso…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm
A completed clinical trial examined the association between nonalcoholic fatty liver disease and colorectal cancer.
-
FDA approval · 2012-08-03FDA Approved: ZALTRAP — Original Application (sanofi-aventis U.S. LLC)
FDA original approval of ZALTRAP (ziv-aflibercept) from Sanofi-U.S. LLC for metastatic colorectal cancer.
-
CLINICAL_TRIALS research · 2012-08-01Clinical Trial Update: Ambulatory Cancer Pain Management: A Feasibility Study
A completed feasibility study sponsored by MD Anderson Cancer Center evaluated ambulatory cancer pain management across multiple cancer type…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors [Phase 2]
Phase 2 completed trial examining preventive treatment for folliculitis caused by EGFR inhibitors in patients with metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Interleukin-12 in Treating Patients With Cancer in the Abdomen [Phase 1]
A Phase 1 trial evaluating interleukin-12 for abdominal cancers, including anal, colorectal, gallbladder, gastric, and pancreatic cancers, h…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients
A completed clinical trial evaluated colon cancer screening in first-degree relatives of Hispanic colorectal cancer patients; sponsored by M…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer [Phase 2]
Phase 2 clinical trial comparing sulindac, aspirin, and ursodiol for colorectal cancer prevention was terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
This completed clinical trial evaluates dose adaptation of capecitabine guided by mobile phone toxicity monitoring in patients with metastat…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients
A completed clinical trial evaluating symptom-related cytokines in patients with anal cancer, colorectal cancer, esophageal cancer, gastric …
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC) [Phase 2]
Phase 2 trial evaluating continuing bevacizumab after first progression in metastatic colorectal cancer has completed.
-
FDA approval · 2012-07-17FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)
FDA-approved the original ANDA for fluorouracil from Eugia US LLC, granting a generic version of fluorouracil for cancer chemotherapy.
-
FDA approval · 2012-07-17FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)
FDA approved the original ANDA for Fluorouracil by Eugia US LLC, enabling the marketing of a generic fluorouracil chemotherapy product.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer [Phase 1]
A Phase I trial tested vandetanib in combination with capecitabine, oxaliplatin and bevacizumab for metastatic colorectal cancer; the study …
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Combination Chemotherapy in Treating Patients With Colorectal Cancer [Phase 2]
A Phase 2 study of combination chemotherapy for colorectal cancer has completed, according to a clinical trial update.